Genmab | GEN - Ordinary Share Capital

Stock Price
1,832.50
Daily Change
-21.00 -1.13%
Monthly
-13.15%
Yearly
14.67%
Q1 Forecast
1,757.86

Genmab reported DKK10M in Ordinary Share Capital for its fiscal quarter ending in March of 2025.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Almirall EUR 214.79M 154.21 Jun/2025
Amarin USD 20.8M 28K Sep/2025
Amgen USD 539M 1000K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bayer EUR 982.42M 0 Sep/2025
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
Demant DKK 210.9M 5.18M Dec/2025
Exelixis USD 268.1M 2.03M Sep/2025
Fresenius Medical Care EUR 289.85M 3.56M Sep/2025
Galapagos EUR 65.9M 0 Sep/2025
Genmab DKK 10M 56M Mar/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
GN Store Nord DKK 145.61M 458.39M Sep/2025
GRIFOLS EUR 679.73M 0 Sep/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Insmed USD 214.26M 1.67M Dec/2025
Lonza CHF 72M 0 Dec/2024
Merck EUR 434.78M 130.22M Jun/2025
Novartis USD 1.94B 23.4M Jun/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
UCB EUR 584M 0 Dec/2024